JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Liver biopsy: review of methodology and complications.

Digestive Diseases 1995 September
Liver biopsy remains an essential tool to confirm a suspected diagnosis and guide specific therapy in patients with liver disease. The methods available to obtain liver tissue include percutaneous needle biopsy, transjugular biopsy, image-guided needle biopsy, and laparoscopic direct vision guided needle biopsy. Advantages and disadvantages of each modality are reviewed herein. The indications for liver biopsy include evaluation of elevated aminotransferases, assessment of response to therapy of chronic liver disease, monitoring for hepatoxicity of drug therapy, and liver transplant allograft evaluation. Contraindications include impaired coagulation, significant ascites, high-grade extrahepatic biliary obstruction, echinococcal cyst, and certain anatomic abnormalities. Complications include pain, hemorrhage, bile peritonitis, penetration of abdominal viscera, pneumothorax, and death. Complications are reported in 0.06-0.32% of the patients. Death as a direct result of liver biopsy is extremely rare (0.009-0.12%). In properly selected patients, liver biopsy has a high benefit/risk ratio and is often considered the final and definitive diagnostic test.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app